Clarivate Insights

Blockchain: disruption or hype? Key webinar takeaways

There is little doubt that blockchain is an emerging technology for a huge number of industries and applications. Is it something that every organization who innovates should pay attention to? What exactly is blockchain, and why is it considered so disruptive? Combining forces with Dr. Nigel Clarke, Head of Patent Information Research for the European […]

Protecting the integrity of the scientific record from a new kind of academic misconduct

At the Web of Science Group, we pride ourselves on protecting the integrity of the scholarly record. We are champions of high editorial standards and research practices, and our global team of in-house, publisher-independent editors are experts in their subjects.  So we are ever-vigilant to trends in unethical research practices, which pose a growing threat […]

Aiming at world pharma stage, China embraces regulatory reforms

With the deepening of the reform of its pharmaceutical industry in the past few years, since joining the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), China has added or amended more and more laws and regulations to meet the needs of the world’s drug developers. During DIA China 2019 […]

Updated Plan S guidance and footprint report

In early June,  Coalition S updated their guidance on the implementation of Plan S. The new, clarified routes to compliance impact the analysis contained within our Global Research Report on The Plan S Footprint, which was issued in March 2019. This blog outlines how the changes in routes to compliance affect our analysis. Firstly, the […]

Record new drug approvals: ‘fleeting success’ or here to stay?

With a record 59 new drugs approved by the FDA and 42 new active substances recommended for authorization by the European Medicines Agency, 2018 was a profoundly productive year for biopharma. In a new analysis, Jamie Munro and Helen Dowden from Clarivate Analytics examine whether 2018 represents “a fleeting success” or if there are underlying […]

The latest Global Research Report: G20 scorecards

Against a current backdrop of tensions in international trade – the Brexit quandary and the tariff duels initiated by US President Donald Trump being just two examples – the Institute for Scientific Information (ISI) of the Web of Science Group™ weighs in with a timely subject for its fourth Global Research Report: a collection of […]

Announcing the 2019 Journal Citation Reports

On June 20, the Web of Science Group™, a Clarivate Analytics company, released the 2019 Journal Citation Reports (JCR). This latest release extends the run of an annual event that stretches back nearly a half century. In that time, the JCR has evolved, with its measurements for journal evaluation refined, expanded and elucidated. This year […]

Biopharma mega mergers remain a force: Q1 analysis

During the first  quarter of 2019, Cortellis Deals Intelligence registered 124 new mergers and acquisitions (M&A), a 24% increase from 100, quarter on quarter vs. last year, as part of its ongoing coverage of M&A activity in the life sciences sector (see Figure 1). However, total disclosed deal value declined by 9% to $119.2 billion […]

Empowering women

The share of female CEOs of Fortune 500 companies reached an all-time high of 6.4% in 2017, with 32 women heading major firms. But the share fell to 4.8% in 2018 after several high-profile women left their posts.[1] In the U.S., women represent 47% of the workforce, yet they hold just 21% of senior leadership […]